A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab

Pulmonary pleomorphic carcinoma is often refractory to chemotherapy and follows an aggressive clinical course. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced lung cancer, and a few cases with pleomorphic carcinoma have been reported to show tumor shrinkage after th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sako, Masahiro, Nokihara, Hiroshi, Kondo, Kensuke, Mitsuhashi, Atsushi, Ozaki, Ryohiko, Yabuki, Yohei, Abe, Akane, Yoneda, Hiroto, Ogino, Hirokazu, Otsuka, Kenji, Uehara, Hisanori, Nishioka, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720630/
https://www.ncbi.nlm.nih.gov/pubmed/34859591
http://dx.doi.org/10.1111/1759-7714.14243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720630/
https://www.ncbi.nlm.nih.gov/pubmed/34859591
http://dx.doi.org/10.1111/1759-7714.14243

Ejemplares similares